Potential Additional Benefits of Cardio-renal-metabolic Therapies on the Incidence of Atrial Fibrillation
Drug therapy for cardio-renal-metabolic diseases can prevent new-onset atrial fibrillation. A meta-analysis investigated which pharmacotherapies have an effect on the risk of new-onset atrial fibrillation.